Rice Bran Wax
Rice Bran Wax
Rice Bran Wax
ISSN: 2278-778X
www.ijbio.com
Research Article
RICE BRAN WAX-A NOVEL EXCEPIENT FOR PHARMACEUTICAL TOPICAL DOSAGE FORMS
Basarkar UG*
PG Department Of Botany, G. E. Societys, H.P.T. Arts & R.Y.K. Science College, Nashik 422 005 (Ms), India
Received for publication: October 27, 2012; Accepted: January 12, 2013.
Abstract: The crude rice bran wax was obtained from M/S Bajaj rice mills, Gondia (MS) which was dark brown in
color & contains nonwaxy impurities & fixed oil. After purification around 38gm wax obtained which was almost
white, light in weight and non-sticky. No instances of skin irritation or sensitization symptoms such as edema /
rending of the skin were observed on the skin of Albino rabbits even after 24 hrs. Therefore wax was nontoxic &
safe to use in pharmaceutical preparations. In the present study the melting range of rice bran wax was found to
be 78840 which is higher, may reduce the diffusion of drug across the layers of skin. Therefore, in the present
study efforts will be made later on to reduce the melting range by addition of low melting point fats like mango
kernel fat (M.P. 34.7oC). Solubility studies reveal that the wax is soluble in organic solvents like chloroform &
petroleum ether showing typical solubility properties of waxes. Refractive index of a compound gives an idea of
purity of the compound & the refractive index of the test sample was found to be 1.44 at 70oc. Sap value of rice
bran wax is 68 72. The acid value of rice bran wax is 12 14. The iodine value of rice bran wax is 9 11. From the
above data the physicochemical properties of rice bran wax was found to be within the range of other waxes used
in topical preparations. Therefore rice bran wax may be utilized as a base in topical preparations. Different topical
formulations such as ointments (oleaginous, modified hydrophilic ointment and modified bellers ointment base)
were formulated with purified rice bran wax and compared with simple ointment (control) and marketed
formulation. All these formulations contain 2% diclofenac sodium. All the formulations were evaluated for p H
rheological studies like apparent viscosity, spread ability and diclofenac sodium content. P H of all formulations
was found to be 5.98 7.30, thus indicating the suitability for application on the skin. Diclofenac sodium content of
all the formulations was found to be above 95% indicating the suitability of the method adopted for preparing the
formulations. Shelf life and release of diclofenac sodium content in vivo study will be made further.
Keywords: Rice bran wax, Topical, Pharmaceutical
INTRODUCTION
Many fats and oils contain a number of minor
components, which are referred as nonglycerides or
waxes. Many of these nonglycerides play an
important role in providing pharmaceutical and
industrial benefits. In fact the recent trends are
directed to explore and establish proper usage of
nonglycerides occurring in the natural lipid materials
like oils and fats. Such trends are considered extremely
important to improve the economy of the lipids and to
meet also the newer possibilities of utilization of the
nonglycerides and derivatives of oils and fats. Many
investigations around the world have already shown
newer pathways for utilizing the nonglycerides in some
specific fields. R and D efforts are still pursued to find
out newer technologies for utilizing the nonglycerides
in a diversified manner. Although waxes are abundant
in nature, a limited numbers only are commercially
used.
During the past few decades a number of non
conventional vegetable oils have been accepted as
good quality edible oils in India and in other countries.
Since India is one of the principle producers of rice in
the world enormous stress is laid upon the extraction
*Corresponding Author:
Dr. Basarkar UG,
Assistant Professor,
P. G. Department Of Botany, G. E. Societys,
H.P.T. Arts & R.Y.K. Science College,
Nashik 422 005 (Ms), India
828
Basarkar UG:
PROPERTTIES
RESULT
1
2
Melting range
Solubility
3
4
5
Refractive index
Specific gravity
Saponificable value
78 84 0C
Soluble in chloroform, Petroleum
ether, Insoluble in Acetone&
Water
1.44 at 70oc
0.93
68 72
6
7
Acid value
Iodine value
12 14
09 11
Unsaponificable
matter
60 - 62
- 43%
- 30%
- 25%
- 02%
www.ijbio.com
PH
Apparent
viscosity
at 100rpm
(cps)
Spreadibility
(Sec)
Diclofenac
sodium
content (%)
6.23
32,200
16
96.20
7.30
22,800
18
95.80
6.72
285,600
45
97.85
5.98
24,250
33
98.04
6.04
16,200
15
98.20
- 20
- 20
- 12
- 01
- 0.025
- 0.015
- 0.10
Formulation
Simple
ointment IP
Rice bran wax
ointment
(Oleaginous
base)
Rice bran wax
ointment
(Modified
hydrophilic
ointment
base)
Rice bran wax
ointment
(Modified
Bellers
ointment
base)
Marketed
formulation
1
2
3
4
5
6
7
8
9
10
Cumulative % of Diclofenac
sodium released *
4.81
8.14
10.73
15.54
19.98
23.31
28.12
30.48
33.74
34.92
Std. Dev.
(+ SD)
0.50
0.30
0.55
0.76
0.74
0.50
1.00
0.57
1.04
0.90
Std. Error
(+ SE)
0.46
0.31
0.42
0.50
0.49
0.40
0.57
0.43
0.58
0.54
- 100
1
2
3
4
5
6
7
8
9
10
Sr.
No.
- 03
- 15
- 10
- 01
- 0.025
- 0.015
- 0.10
- 02
- 100
Cumulative % of Diclofenac
sodium released *
4.29
6.069
8.95
11.24
14.50
16.42
19.61
22.57
25.97
29.82
829
Std. Dev.
(+ SD)
0.05
0.10
0.60
0.30
0.09
0.20
0.60
0.35
0.80
0.35
Std. Error
(+ SE)
0.13
0.18
0.44
0.32
0.17
0.26
0.44
0.34
0.52
0.34
Basarkar UG:
Cumulative % of Diclofenac
sodium released *
6.06
10.43
19.68
22.94
28.34
34.18
39.51
42.18
45.73
48.61
Std. Dev. (+
SD)
0.05
0.08
0.08
0.13
0.27
0.06
0.05
0.20
0.12
0.07
Std. Error (+
SE)
0.13
0.16
0.16
0.21
0.30
0.14
0.13
0.26
0.20
0.15
40
35
30
25
20
15
10
5
0
Cumulative %
Hour
Std. Dev. (+
SD)
0.50
0.58
1.52
0.58
1.02
1.15
1.21
1.15
1.53
1.58
Std. Error (+
SE)
0.41
0.44
0.71
0.44
0.58
1.73
1.78
1.73
0.50
0.44
10
0
1
10
Hours
Std. Dev. (+
SD)
1.04
1.15
1.04
1.53
0.52
1.00
1.53
1.00
1.53
0.58
Std. Error (+
SE)
0.59
0.42
0.59
0.71
0.41
0.58
0.71
0.58
0.71
0.44
60
Cumulative %
1
2
3
4
5
6
7
8
9
10
Diclofenac
11
20
10
30
Hour
40
Cum ulative %
1
2
3
4
5
6
7
8
9
10
Cumulative % of Diclofenac
sodium released *
5.77
11.84
18.64
28.12
31.22
38.33
43.06
46.40
51.94
59.94
Hours
50
40
30
20
10
0
1
10
Hours
1
2
3
4
5
6
7
8
9
10
Rice bran
wax
ointment
(Oleaginous
base)
4.81
8.14
10.73
15.54
19.98
23.31
28.12
30.48
33.74
34.92
4.29
6.06
8.95
11.24
14.50
16.42
19.61
22.57
25.97
29.82
5.77
11.84
18.64
28.12
31.22
38.33
43.06
46.40
51.94
59.60
Rice bran
wax
ointment
(Modified
Bellers
ointment
base)
6.06
10.43
19.68
22.94
28.34
34.18
39.51
42.18
45.73
48.61
50
40
30
20
10
Marketed 0
formulation
9.69
17.98
26.34
38.33
45.06
54.61
64.38
71.63
78.36
84.50
10
Hours
www.ijbio.com
Hours
C u m u la t iv e %
Hour
Simple
ointment
IP
(Control)
Rice bran
wax
ointment
(Modified
hydrophilic
ointment
base)
60
Cumulative %
830
10
Basarkar UG:
Cumulative %
100
80
60
40
20
0
1
10
Hours
Simple ointment IP (Control)
Rice bran wax ointment (Oleaginous base)
Rice bran wax ointment (Modified hydrophilic ointment base)
Rice bran wax ointment (Modified Bellers ointment base)
Marketed formulation
www.ijbio.com
831
Basarkar UG:
6.
7.
8.
9.
10.
11.
12.
13.
REFERENCES
1.
2.
3.
Buffa CW, (1976) Rice bran wax A new wax for cosmetics,
drugs & toiletries. Cosmet. Toiletries, 91, 10: 14 16.
Draize JH, Woodward C, Calvery HO, J. Pharmacol. Exp. Therap.,
(1944) Ph. D. Thesis Nagpur Univ., (1990) Comparative
evaluation of rosin & abietic acid derivatives as cosmetic
materials. 82, 377.
Edwin RC, Fore SP, Janseen HJ and Feuge RO (1953) Rice bran
oil. VII. Tank settlings from crude rice bran oil as a source of
wax. J. Am. Oil Chem. Soc., 30: 9 14.
4.
5.
www.ijbio.com
832